Context: Boosting competitiveness is a key priority for European Commission president Ursula von der Leyen, who is pushing to ...

Researchers have developed a new oral drug that boosts metabolic activity in muscle rather than altering appetite like GLP-1 ...

Gen Z are going retro, with studies showing a resurgence in people buying tech in the modern age that can be dated back ...

In Delfi's 9MFY2025 ended September, revenue of US$384 million was below Yeo's estimates. The slight growth was driven by ...

A groundbreaking experimental pill shows promise for weight loss, potentially allowing individuals to shed fat without ...

His SpaceX rocket-launch company is considering an IPO that would value the business at about $1.5 trillion, according to ...

Scientists in Sweden have created a new pill designed to help the body burn fat and control blood sugar in a different way than popular GLP-1 drugs, like Ozempic. While injectable GLP-1s work by ...

Three officials dissented in opposite directions. Stalled progress on inflation and a cooling job market made for one of the ...

Luxury interiors are pivoting away from quiet minimalism and toward something far more nostalgic and theatrical. Across ...

Nifty is currently trading at 25,757, down 0.78 per cent. The advances/declines ratio is at 1:49. This is very negative.

The documentary films and series that captured our attention this year feature famous people and ordinary people, as well as ...

Dec 10 (Reuters) - The Trump administration will hold the government's first sale of oil and gas drilling rights in the Gulf ...